Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Tatva Chintan Pharma Chem's average Book Value Per Share Growth Rate was 5.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 12.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 29.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Tatva Chintan Pharma Chem was 81.10% per year. The lowest was 12.90% per year. And the median was 61.40% per year.
Tatva Chintan Pharma Chem (NSE:TATVA) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Tatva Chintan Pharma Chem Book Value per Share Related Terms
Tatva Chintan Pharma Chem Book Value per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem Book Value per Share Chart
NSE:TATVA vs LIN, SHW, ECL: Book Value per Share Comparison
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's PB Ratio distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (NSE:TATVA) has a Book Value per Share of ₹0.00 as of Jun. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Book Value per Share too high?
Tatva Chintan Pharma Chem's current Book Value per Share is ₹0.00. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Book Value per Share compare to LIN and SHW?
Tatva Chintan Pharma Chem's Book Value per Share of ₹0.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Chemicals company?
A good Book Value per Share depends on the Chemicals industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Book Value per Share is ₹0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,529.31, compared to a current price of ₹1,630.00 — trading 6.6% above its estimated fair value. The current Book Value per Share is ₹0.00. Tatva Chintan Pharma Chem's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Book Value per Share is ₹0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued.
The current stock price of ₹1,630.00 is trading 6.6% above its estimated GF Value™ of ₹1,529.31.
GuruFocus considers Tatva Chintan Pharma Chem to be Fairly Valued.
Key valuation signals for NSE:TATVA:
Book Value per Share: ₹0.00
GF Value™: ₹1,529.31 vs. price of ₹1,630.00 (6.6% above fair value)
No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
80GF Score
Get the complete analysis for NSE:TATVA
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:TATVA has been successfully added to your 
